SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-08-001878
Filing Date
2008-02-20
Accepted
2008-02-20 06:03:05
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y49949e10vk.htm 10-K 1462481
2 EX-21.1: LIST OF SUBSIDIARIES y49949exv21w1.htm EX-21.1 16938
3 EX-23.1: CONSENT OF KPMG LLP y49949exv23w1.htm EX-23.1 5238
4 EX-31.1: CERTIFICATION y49949exv31w1.htm EX-31.1 9221
5 EX-31.2: CERTIFICATION y49949exv31w2.htm EX-31.2 9024
6 EX-32.1: CERTIFICATION y49949exv32w1.htm EX-32.1 3423
7 EX-32.2: CERTIFICATION y49949exv32w2.htm EX-32.2 3432
8 GRAPHIC y49949y4994902.gif GRAPHIC 9385
  Complete submission text file 0000950123-08-001878.txt   1524209
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 0501
Type: 10-K | Act: 34 | File No.: 000-16132 | Film No.: 08628297
SIC: 2834 Pharmaceutical Preparations